Anti-CLEC14A Neutralizing Antibody (V3S-0723-FY205) (CAT#: V3S-0723-FY205)

Send Inquiry
  • fig1

Datasheet

MSDS

COA

Summary
Property
Applications
Protocols
Target

Summary

Description The C5 monoclonal antibody (mAb) is a mouse-derived recombinant antibody designed to specifically target human CLEC14A. By binding to CLEC14A, the C5 antibody effectively blocks the interaction between CLEC14A and MMRN2.
Clonality Monoclonal
Host Species Mouse
Target Species human
Isotype IgG

Property

Expression Species HEK293F or CHO cell line
Conjugation Unconjugated
Purity >95%
Endotoxin <1 EU/mg
Form Liquid
Purification Protein G purified
Sterility 0.2 μM filtered
Formulation PBS, pH 7.4
Preservation No preservatives
Stabilizer No stabilizers
Storage Store at 4°C within one or two weeks. Store at -20°C for long term. Avoid repeated freeze/thaw cycles. Refer to the COA file for specifics.

Applications

Application FC; Block

Protocols

ELISA Enzyme-Linked Immunosorbent Assay Protocol
WB Western Blot Protocol
FC Flow Cytometry Protocol

Target

Target CLEC14A
Alternative Name C-Type Lectin Domain Containing 14A; C-Type Lectin Domain Family 14 Member A; Epidermal Growth Factor Receptor 5; C14orf27; EGFR-5; ClECT And EGF-Like Domain Containing Protein
Gene ID 161198
UniProt Q86T13
Research Area Cell Biology
For research use only, not directly for clinical use.
banner banner
© 2024 Creative Biolabs. All Rights Reserved.
antibody
Online Inquiry